Scott Rudge, PhD

CMC Development Lead

Novateur Advisor Since





CMC Supply Chain, Logistics & Procurement, CRO, CDMO, Material Vendor Selection & Management

Dr. Scott Rudge joined the pharma/biotech industry in 1989, and has served as the Chairman/COO of RMC Pharmaceutical Solutions since helping to co-found the company in May 2004 (RMC was acquired by Syner-G BioPharma Group in 2023). Scott has been involved in a wide variety of projects for small and large biotech/pharmaceutical companies, including serving in multiple embedded senior/executive management roles. He has also overseen and/or performed assay, equipment, sterilization, cleaning and process validation, formulation development, due diligence for a multimillion-dollar investment, construction of a new GMP facility for tissue processing, and tech transfer for a major late-stage biotechnology product. In his last full-time position prior to co-founding RMC, Scott served as the Vice President of Operations at FeRx Incorporated, overseeing manufacturing, process and product development, analytical development, formulation, facility design, construction and operation, and intellectual property.

Novateur Newsletter

Subscribe to our newsletter for access to latest updates.

Resource Databases

Access Novateur news as well as FDA and Expert Databases.

Relevant Events

Check out conferences and events we are attending!